(Q46827137)

English

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

scientific article published on 29 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

George Fountzilas

8

object named as

G Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

author name string

M Karthaus

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

A Kretzschmar

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

H Kröning

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

M Biakhov

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

D Irwin

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

N Marschner

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

C Slabber

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

A Garin

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

N G F Abecasis

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

W Baronius

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

G G Steger

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

T Südhoff

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

C Giorgetti

14

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

P Reichardt

15

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

publication date

29 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

17

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

289-296

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

The thrombophilic state induced by therapeutic agents in the cancer patient

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Thrombotic complications of central venous catheters in cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Venous thrombosis associated with the placement of peripherally inserted central catheters

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Venous thrombosis and pulmonary embolism. A study of 5039 autopsies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

A review of 560 Hickman catheter insertions

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Venous thromboembolism and cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Complications of indwelling venous access devices in cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Long-term follow-up of upper extremity implanted venous access devices in oncology patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ059

21 January 2018

Identifiers

10.1093/ANNONC/MDJ059

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16317012

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46827137&oldid=2133780379"